2022

1. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

   Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4

2. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

   Viruses, Vol. 14, Núm. 2